Additionally, leptin resistance and reduced UCP2 expression initiated in the early stage of T2DM might be potential triggers to cause CVP neuronal dysfunction, and further result in attenuation of cardiovascular parasympathetic activation and cardiac arrhythmogenesis during the progression of T2DM. The gene discussed is UCP2; the disease is type 2 diabetes mellitus.